BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 36566836)

  • 1. ESCMID/EUCIC clinical practice guidelines on perioperative antibiotic prophylaxis in patients colonized by multidrug-resistant Gram-negative bacteria before surgery.
    Righi E; Mutters NT; Guirao X; Del Toro MD; Eckmann C; Friedrich AW; Giannella M; Kluytmans J; Presterl E; Christaki E; Cross ELA; Visentin A; Sganga G; Tsioutis C; Tacconelli E
    Clin Microbiol Infect; 2023 Apr; 29(4):463-479. PubMed ID: 36566836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ESCMID-EUCIC clinical guidelines on decolonization of multidrug-resistant Gram-negative bacteria carriers.
    Tacconelli E; Mazzaferri F; de Smet AM; Bragantini D; Eggimann P; Huttner BD; Kuijper EJ; Lucet JC; Mutters NT; Sanguinetti M; Schwaber MJ; Souli M; Torre-Cisneros J; Price JR; Rodríguez-Baño J
    Clin Microbiol Infect; 2019 Jul; 25(7):807-817. PubMed ID: 30708122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine).
    Paul M; Carrara E; Retamar P; Tängdén T; Bitterman R; Bonomo RA; de Waele J; Daikos GL; Akova M; Harbarth S; Pulcini C; Garnacho-Montero J; Seme K; Tumbarello M; Lindemann PC; Gandra S; Yu Y; Bassetti M; Mouton JW; Tacconelli E; Rodríguez-Baño J
    Clin Microbiol Infect; 2022 Apr; 28(4):521-547. PubMed ID: 34923128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for colonization with multidrug-resistant Gram-negative bacteria and
    Azzini AM; Be G; Naso L; Lambertenghi L; Salerno ND; Coledan I; Bazaj A; Mirandola M; Miotti J; Mazzaferri F; Accordini S; Lo Cascio G; Tacconelli E
    Front Cell Infect Microbiol; 2023; 13():1155320. PubMed ID: 37377644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bloodstream infections due to Gram-negative bacteria in patients with hematologic malignancies: updated epidemiology and risk factors for multidrug-resistant strains in an Italian perspective survey.
    Trecarichi EM; Giuliano G; Cattaneo C; Ballanti S; Criscuolo M; Candoni A; Marchesi F; Laurino M; Dargenio M; Fanci R; Cefalo M; Delia M; Spolzino A; Maracci L; Bonuomo V; Busca A; Principe MID; Daffini R; Simonetti E; Dragonetti G; Zannier ME; Pagano L; Tumbarello M;
    Int J Antimicrob Agents; 2023 Jun; 61(6):106806. PubMed ID: 37030470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survey on the approach to antibiotic prophylaxis in liver and kidney transplant recipients colonized with "difficult to treat" Gram-negative bacteria.
    Bonazzetti C; Rinaldi M; Cosentino F; Gatti M; Freire MP; Mularoni A; Clemente WT; Pierrotti LC; Aguado JM; Grossi P; Pea F; Viale P; Giannella M;
    Transpl Infect Dis; 2024 Apr; 26(2):e14238. PubMed ID: 38265107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review on efficacy of preventive measures for surgical site infection by multiple-drug resistant gram-negative bacilli.
    Matos JA; Gomes ADS; Lima COGX; Schmaltz CAS; Oliveira CR; Silva GMD; Carijó JH; Lopes MA; Morais QCD; Brasil PEAAD
    Braz J Infect Dis; 2022; 26(6):102705. PubMed ID: 36228664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory diagnosis, clinical management and infection control of the infections caused by extensively drug-resistant Gram-negative bacilli: a Chinese consensus statement.
    ; Guan X; He L; Hu B; Hu J; Huang X; Lai G; Li Y; Liu Y; Ni Y; Qiu H; Shao Z; Shi Y; Wang M; Wang R; Wu D; Xie C; Xu Y; Yang F; Yu K; Yu Y; Zhang J; Zhuo C
    Clin Microbiol Infect; 2016 Mar; 22 Suppl 1():S15-25. PubMed ID: 26627340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor-derived carbapenem-resistant gram-negative bacterial infections in solid organ transplant recipients: Active surveillance enhances recipient safety.
    Mularoni A; Cona A; Campanella M; Barbera F; Medaglia AA; Cervo A; Cuscino N; Di Mento G; Graziano E; El Jalbout JD; Alduino R; Tuzzolino F; Monaco F; Cascio A; Peghin M; Gruttadauria S; Bertani A; Conaldi PG; Mikulska M; Grossi PA
    Am J Transplant; 2024 Jun; 24(6):1046-1056. PubMed ID: 38342183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of and risk factors for intestinal colonisation by multidrug-resistant Gram-negative bacteria in patients with haematological malignancies: A systematic review and meta-analysis.
    Luo H; Chen X; Jiang Z; Yan Q
    Int J Antimicrob Agents; 2024 Jan; 63(1):107043. PubMed ID: 38040318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choice of therapeutic interventions and outcomes for the treatment of infections caused by multidrug-resistant gram-negative pathogens: a systematic review.
    Nørgaard SM; Jensen CS; Aalestrup J; Vandenbroucke-Grauls CMJE; de Boer MGJ; Pedersen AB
    Antimicrob Resist Infect Control; 2019; 8():170. PubMed ID: 31709047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of infections caused by multidrug-resistant Gram-negative bacteria: report of the British Society for Antimicrobial Chemotherapy/Healthcare Infection Society/British Infection Association Joint Working Party.
    Hawkey PM; Warren RE; Livermore DM; McNulty CAM; Enoch DA; Otter JA; Wilson APR
    J Antimicrob Chemother; 2018 Mar; 73(suppl_3):iii2-iii78. PubMed ID: 29514274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guidelines for the diagnosis, treatment, prevention and control of infections caused by carbapenem-resistant gram-negative bacilli.
    Zeng M; Xia J; Zong Z; Shi Y; Ni Y; Hu F; Chen Y; Zhuo C; Hu B; Lv X; Li J; Liu Z; Zhang J; Yang W; Yang F; Yang Q; Zhou H; Li X; Wang J; Li Y; Ren J; Chen B; Chen D; Wu A; Guan X; Qu J; Wu D; Huang X; Qiu H; Xu Y; Yu Y; Wang M; ; ;
    J Microbiol Immunol Infect; 2023 Aug; 56(4):653-671. PubMed ID: 36868960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria.
    Zhanel GG; Pozdirca M; Golden AR; Lawrence CK; Zelenitsky S; Berry L; Schweizer F; Bay D; Adam H; Zhanel MA; Lagacé-Wiens P; Walkty A; Irfan N; Naber K; Lynch JP; Karlowsky JA
    Drugs; 2022 Apr; 82(5):533-557. PubMed ID: 35294769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Impact of antimicrobial stewardship program on antimicrobial usage and detection rate of multidrug-resistant gram-negative bacteria].
    Xu YL; Hu LM; Xie ZZ; Dong YW; Dong L
    Zhonghua Er Ke Za Zhi; 2019 Jul; 57(7):553-558. PubMed ID: 31269557
    [No Abstract]   [Full Text] [Related]  

  • 16. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
    Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA
    Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of combination therapy in the treatment of severe infections caused by carbapenem resistant gram-negatives: a systematic review of clinical studies.
    Savoldi A; Carrara E; Piddock LJV; Franceschi F; Ellis S; Chiamenti M; Bragantini D; Righi E; Tacconelli E
    BMC Infect Dis; 2021 Jun; 21(1):545. PubMed ID: 34107899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical data from studies involving novel antibiotics to treat multidrug-resistant Gram-negative bacterial infections.
    Kanj SS; Bassetti M; Kiratisin P; Rodrigues C; Villegas MV; Yu Y; van Duin D
    Int J Antimicrob Agents; 2022 Sep; 60(3):106633. PubMed ID: 35787918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Executive summary of the consensus document of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) on the diagnosis and antimicrobial treatment of infections due to carbapenem-resistant Gram-negative bacteria.
    Pintado V; Ruiz-Garbajosa P; Aguilera-Alonso D; Baquero-Artigao F; Bou G; Cantón R; Grau S; Gutiérrez-Gutiérrez B; Larrosa N; Machuca I; Martínez Martínez L; Montero MM; Morte-Romea E; Oliver A; Paño-Pardo JR; Sorlí L
    Enferm Infecc Microbiol Clin (Engl Ed); 2023; 41(6):360-370. PubMed ID: 36522272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of broad-spectrum antibiotic exposures and multidrug-resistant gram-negative bacteremia on hematopoietic cell transplantation outcomes.
    Kaundal S; Jandial A; Singh H; Chopra M; Kasudhan KS; Khaire N; Khadwal A; Prakash G; Jain A; Suri V; Patil A; Arora A; Sharma V; Ray P; Malhotra P; Lad DP
    Transpl Infect Dis; 2021 Oct; 23(5):e13717. PubMed ID: 34431187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.